세계의 자동 샘플 보관 시스템 시장 : 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Automated Sample Storage Systems Market was valued at USD 1.3 billion in 2024 and is estimated to grow at a CAGR of 11.1% to reach USD 3.6 billion by 2034. This strong growth trajectory is driven by the rising demand for biorepositories, increased focus on preserving sample integrity, and digital transformation within life science and clinical laboratories. As drug development and genomic research advance, laboratories across the globe are turning to automation for more accurate, secure, and scalable sample management. The integration of automated storage systems with lab digitization tools, such as laboratory information management systems (LIMS), enhances sample tracking, inventory control, and data accuracy.

The growing investment in large-scale research programs and public health biobanks is fueling the need for scalable, tech-driven storage solutions. Automated systems help labs reduce human error, maintain compliance, and support high-throughput workflows, especially in pharmaceutical, biotech, and clinical settings. As sample volumes and data complexity rise, automation is becoming a cornerstone of efficient lab operations, shaping the future of modern laboratory infrastructure and clinical research environments.

In 2024, the automated compound storage systems segment generated USD 721.3 million. These systems play a critical role in pharmaceutical discovery by enabling large-scale chemical library storage with minimal manual intervention. Their ability to streamline compound retrieval and ensure consistency makes them vital to drug screening workflows and pharmaceutical R&D operations. The need for reliable compound management continues to grow due to increasing chemical library sizes and demand for reproducible results in high-throughput environments.

The compound sample segment held a 59.4% share in 2024, driven by rising applications in fast-paced screening environments. As pharmaceutical companies seek faster turnaround times, automated solutions offering precise tracking, temperature control, and robotic handling help enhance compound screening workflows, ultimately reducing timelines and improving efficiency in drug discovery.

U.S. Automated Sample Storage Systems Market generated USD 472.5 million in 2024, solidifying its position as a key regional contributor. North America's leadership stems from a strong presence of pharmaceutical and biotech companies actively using automation in sample storage. The region also hosts major biobank facilities that serve research programs, further boosting demand for scalable and secure sample management systems. The ongoing expansion of drug discovery pipelines and the push for precision medicine are also driving regional adoption of advanced storage solutions.

Leading players shaping the Global Automated Sample Storage Systems Market include Thermo Fisher Scientific, Brooks Automation, MEGAROBO, ASKION, Panasonic Healthcare, TTP LabTech, Biotron Healthcare, SPT Labtech, Beckman Coulter, Haier Biomedical, Angelantoni Life Science, LiCONiC, Azenta, Hamilton Company, and MICRONIC. Key companies in the automated sample storage systems market are focusing heavily on enhancing technology integration, expanding global distribution channels, and developing systems tailored to evolving customer needs. Many are investing in next-gen robotics, AI-based sample tracking, and cloud-based software for seamless connectivity with lab informatics platforms. Companies are also strengthening their regional presence through strategic partnerships and acquisitions, particularly in emerging biopharma hubs.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Product
  • 2.2.3 Sample
  • 2.2.4 End use
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Factor affecting the value chain
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing need for biobanking and maintaining biorepositories
    • 3.2.1.2 Digital transformation across clinical and research laboratories
    • 3.2.1.3 Growth in drug discovery and development
    • 3.2.1.4 Growing focus on sample integrity and compliance
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Requirement of substantial initial capital investments
    • 3.2.2.2 Concerns related to data security and backup
  • 3.2.3 Market opportunities
    • 3.2.3.1 Technological advancements in AI and IoT
    • 3.2.3.2 Growing demand for bundled one-stop solutions
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East and Africa
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Future market trends
• 3.7 Patent analysis
• 3.8 Pricing analysis
  • 3.8.1 By product
  • 3.8.2 By region
• 3.9 Gap analysis
• 3.10 Porter's analysis
• 3.11 PESTLE analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Automated compound storage systems
• 5.3 Automated liquid handling systems
• 5.4 Other products

Chapter 6 Market Estimates and Forecast, By Sample, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Compound sample
• 6.3 Biological sample
• 6.4 Other samples

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Pharmaceutical and biotechnology companies
• 7.3 Academic and research institutes
• 7.4 Biobanks
• 7.5 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profile

• 9.1 Angelantoni Life Science
• 9.2 ASKION
• 9.3 Azenta US
• 9.4 Beckman Coulter
• 9.5 Biotron Healthcare
• 9.6 Brooks Automation
• 9.7 Haier Biomedical
• 9.8 Hamilton Company
• 9.9 LiCONiC
• 9.10 MEGAROBO
• 9.11 MICRONIC
• 9.12 Panasonic Healthcare
• 9.13 SPT Labtech
• 9.14 Thermo Fisher Scientific
• 9.15 TTP LabTech